Clinical Trial Update: Effects of Ketone Bodies on Cognition in Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated whether ketone bodies affect cognitive function in individuals with Type 2 diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Bispebjerg Hospital | Conditions: Type2 Diabetes, Ketonemia | Phase 1 | Status: COMPLETED